Discover
GH
Guardant Health, Inc.
170.77
2 x 157.62
2 x 182.02
bid
ask
+
20.74
13.82%
2 @ 07:41 AM
171.29 +0.52 (0.30%)
| Ytd | 67.19% | |
| 1y | 236.76% |
156.16
day range
172.60
40.35
52 week range
172.61
| Open | 160.75 | Prev Close | 150.03 | Low | 156.16 | High | 172.60 | Mkt Cap | 22.64B |
| Vol | 6.66M | Avg Vol | 2.65M | EPS | -3.40 | P/E | N/A | Forward P/E | -435.81 |
| Beta | 1.62 | Short Ratio | 5.33 | Inst. Own | 105.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 115.33 | 200-d Avg | 97.35 | 1yr Est | 144.42 |
| Income Statement | |||
| Total Revenue | 301.67M | ||
| Revenues (USD) | 301.67M | ||
| Cost of Revenue | 104.92M | ||
| Gross Profit | 196.75M | ||
| Operating Expenses | 318.10M | ||
| Research and Development Expense | 91.04M | ||
| Selling, General and Administrative Expense | 227.06M | ||
| Operating Income | -121.35M | ||
| Interest Expense | 1.35M | ||
| Income Tax Expense | 372.00K | ||
| Net Income | -112.07M | ||
| Net Income Common Stock | -112.07M | ||
| Net Income Common Stock (USD) | -112.07M | ||
| Consolidated Income | -112.07M | ||
| Earnings per Basic Share | -0.85 | ||
| Earnings per Basic Share (USD) | -0.85 | ||
| Earnings per Diluted Share | -0.85 | ||
| Earning Before Interest & Taxes (EBIT) | -110.36M | ||
| Earning Before Interest & Taxes (USD) | -110.36M | ||
| Weighted Average Shares | 131.27M | ||
| Weighted Average Shares Diluted | 131.27M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.10B | ||
| Cash and Equivalents (USD) | 1.10B | ||
| Investments | 113.47M | ||
| Investments Current | 113.47M | ||
| Trade and Non-Trade Receivables | 137.40M | ||
| Current Assets | 1.37B | ||
| Property, Plant & Equipment Net | 303.94M | ||
| Total Assets | 1.92B | ||
| Total Debt | 1.68B | ||
| Current Liabilities | 292.15M | ||
| Debt Non-Current | 1.68B | ||
| Total Liabilities | 2.10B | ||
| Accumulated Retained Earnings (Deficit) | -3.11B | ||
| Accumulated Other Comprehensive Income | -5.15M | ||
| Shareholders Equity | -181.07M | ||
| Shareholders Equity (USD) | -181.07M | ||
| Assets Non-Current | 547.79M | ||
| Total Debt (USD) | 1.68B | ||
| Deferred Revenue | 47.77M | ||
| Goodwill and Intangible Assets | 102.80M | ||
| Inventory | 83.85M | ||
| Liabilities Non-Current | 1.80B | ||
| Trade and Non-Trade Payables | 75.03M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 9.44M | ||
| Net Cash Flow from Financing | -21.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 612.02M | ||
| Capital Expenditure | -5.58M | ||
| Issuance (Purchase) of Equity Shares | 3.65M | ||
| Issuance (Repayment) of Debt Securities | -102.00K | ||
| Net Cash Flow from Investing | 699.42M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 705.00M | ||
| Net Cash Flow from Operations | -65.62M | ||
| Effect of Exchange Rate Changes on Cash | -194.00K | ||
| Share Based Compensation | 47.61M | ||